Products January 10, 2001

AMIDEX Offers Cancer Cure Fund

October 1, 2001(PLANSPONSOR.com) -AMIDEX Mutual Funds, Inc. has launched the first index mutual fund that allows investors to support the battle against cancer.
Reported by

The AMIDEX Cancer Innovations & Healthcare Mutual Fund will invest in the 45 pharmaceutical, biotechnology and medical device companies that comprise the AMIDEX eMed Cancer Innovations & Healthcare Index, published and calculated by eMedsecurities, Inc.

The new offering is the only fund that invests solely in companies involved in the diagnosis and treatment of cancer.

Never miss a story — sign up for PLANSPONSOR newsletters to keep up on the latest retirement plan benefits news.

The index includes:

  • pharmaceutical giants Merck, Pfizer and Abbott,
  • biotech leaders Chiron and Genentech, and
  • medical equipment companies Beckman Coulter and Cytyc

During October, the AMIDEX Cancer Innovations & Healthcare Mutual Fund shares can be purchased through without a sales load.

More information on the eMed Cancer Innovations & Healthcare Index is available at www.emedsecurities.com .

«